G1 Therapeutics.

> G1 Therapeutics raised $50 million through a stock offering with plans to invest in more clinical trials. The oncology company received FDA approval for its Cosela oncology...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT